Human TMEM209/NET31 ORF/cDNA clone-Lentivirus particle (NM_032842)
Cat. No.: vGMLP001047
Pre-made Human TMEM209/NET31 Lentiviral expression plasmid for TMEM209 lentivirus packaging, TMEM209 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.
Go to
TMEM209/NET31 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Catalog No. | Product Name | lentivirus Grade | lentivirus quantity |
---|---|---|---|
vGMLP001047 | Human TMEM209 Lentivirus particle | Pilot Grade | 1.0E+8TU |
5.0E+8TU | |||
1.0E+9TU | |||
Research Grade | 1.0E+8TU | ||
5.0E+8TU | |||
1.0E+9TU | |||
GMP-like Grade | inquiry | ||
GMP Grade | inquiry |
Product Description
Catalog ID | vGMLP001047 |
Gene Name | TMEM209 |
Accession Number | NM_032842 |
Gene ID | 84928 |
Species | Human |
Product Type | Lentivirus particle (overexpression) |
Insert Length | 1686 bp |
Gene Alias | NET31 |
Fluorescent Reporter | ZsGreen |
Mammalian Cell Selection | Puromyocin |
Fusion Tag | 3xflag (C-Terminal) |
Promoter | CMV |
Resistance | Amplicin |
ORF Nucleotide Sequence | ATGATGCAGGGGGAGGCACACCCTAGTGCTTCCCTTATTGACAGAACCATCAAGATGAGAAAAGAAACAGAGGCTAGGAAAGTGGTCTTAGCCTGGGGACTCCTAAATGTATCTATGGCTGGAATGATATATACTGAAATGACTGGAAAATTGATTAGTTCATACTACAATGTGACATACTGGCCCCTCTGGTATATTGAGCTTGCCCTTGCATCTCTCTTCAGCCTTAATGCCTTATTTGATTTTTGGAGATATTTCAAATATACTGTGGCACCAACAAGTCTGGTTGTTAGTCCTGGACAGCAAACACTTTTAGGGTTGAAAACAGCTGTTGTACAGACTACGCCTCCACATGATCTGGCAGCAACCCAAATCCCTCCCGCTCCACCTTCCCCTTCAATTCAGGGTCAGAGTGTGTTGAGTTATAGCCCTTCTCGTTCGCCCAGTACCAGTCCCAAGTTCACCACCAGCTGTATGACTGGTTACAGCCCTCAGCTGCAAGGTCTGTCCTCAGGTGGCAGTGGTTCTTATAGCCCTGGAGTGACCTACTCGCCCGTCAGTGGTTATAATAAGTTGGCGAGCTTTAGCCCCTCTCCTCCTTCTCCGTACCCTACCACTGTTGGACCAGTGGAGAGCAGTGGATTGAGATCTCGCTACCGTTCTTCACCTACCGTCTACAACTCACCTACTGACAAAGAAGACTACATGACCGACCTACGAACTTTGGATACTTTTCTCAGAAGTGAAGAGGAGAAACAGCATAGGGTTAAGCTGGGGAGCCCAGATTCTACCTCTCCTTCCAGCAGTCCTACTTTCTGGAACTATAGTCGTTCTATGGGGGATTATGCACAAACTTTAAAGAAGTTTCAGTATCAGCTTGCCTGTAGGTCTCAGGCCCCATGTGCTAACAAAGATGAAGCCGATCTCAGCTCTAAACAAGCCGCAGAAGAGGTCTGGGCAAGAGTGGCTATGAATAGACAACTTCTTGATCATATGGATTCATGGACAGCTAAATTTAGAAATTGGATCAATGAGACAATATTAGTGCCACTTGTTCAAGAGATTGAGTCTGTCAGCACACAGATGAGACGAATGGGTTGTCCAGAGCTACAGATAGGAGAGGCTAGTATTACTAGCTTGAAACAAGCTGCCCTGGTTAAAGCGCCTCTCATTCCGACTTTGAACACAATCGTTCAGTATCTAGACCTTACTCCAAATCAGGAATACTTGTTTGAAAGGATCAAAGAACTATCTCAGGGAGGTTGTATGAGCTCATTTCGATGGAACAGAGGTGGCGACTTCAAAGGACGAAAGTGGGATACAGACCTGCCCACCGATTCTGCTATCATCATGCATGTATTTTGCACCTACCTTGATTCCAGATTACCTCCACATCCGAAGTATCCCGACGGAAAAACTTTTACTTCTCAGCACTTTGTTCAGACACCAAATAAACCAGATGTTACAAATGAGAATGTTTTTTGCATTTATCAGAGTGCTATCAACCCTCCCCATTATGAGCTCATCTACCAGCGTCATGTATACAACCTGCCAAAGGGCAGAAATAATATGTTTCATACATTGTTGATGTTTCTCTACATCATAAAGACCAAAGAGTCAGGAATGCTTGGGAGAGTTAATCTTGGTCTATCTGGTGTGAATATATTGTGGATCTTTGGCGAGTAG |
ORF Protein Sequence | MMQGEAHPSASLIDRTIKMRKETEARKVVLAWGLLNVSMAGMIYTEMTGKLISSYYNVTYWPLWYIELALASLFSLNALFDFWRYFKYTVAPTSLVVSPGQQTLLGLKTAVVQTTPPHDLAATQIPPAPPSPSIQGQSVLSYSPSRSPSTSPKFTTSCMTGYSPQLQGLSSGGSGSYSPGVTYSPVSGYNKLASFSPSPPSPYPTTVGPVESSGLRSRYRSSPTVYNSPTDKEDYMTDLRTLDTFLRSEEEKQHRVKLGSPDSTSPSSSPTFWNYSRSMGDYAQTLKKFQYQLACRSQAPCANKDEADLSSKQAAEEVWARVAMNRQLLDHMDSWTAKFRNWINETILVPLVQEIESVSTQMRRMGCPELQIGEASITSLKQAALVKAPLIPTLNTIVQYLDLTPNQEYLFERIKELSQGGCMSSFRWNRGGDFKGRKWDTDLPTDSAIIMHVFCTYLDSRLPPHPKYPDGKTFTSQHFVQTPNKPDVTNENVFCIYQSAINPPHYELIYQRHVYNLPKGRNNMFHTLLMFLYIIKTKESGMLGRVNLGLSGVNILWIFGE |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
---|---|---|
Target Antibody | GM-Tg-g-IP2043-Ab | Anti-TMEM209 monoclonal antibody |
Target Antigen | GM-Tg-g-IP2043-Ag | TMEM209 protein |
ORF Viral Vector | pGMLP001047 | Human TMEM209 Lentivirus plasmid |
ORF Viral Vector | vGMLP001047 | Human TMEM209 Lentivirus particle |
Target information
Target ID | GM-IP2043 |
Target Name | TMEM209 |
Gene Group Identifier (Target Gene ID in Homo species) |
84928 |
Gene ID |
100071970 (Equus caballus), 101092922 (Felis catus), 312200 (Rattus norvegicus), 475194 (Canis lupus familiaris) 510567 (Bos taurus), 706578 (Macaca mulatta), 72649 (Mus musculus), 84928 (Homo sapiens) |
Gene Symbols & Synonyms | TMEM209,Tmem209,RGD1309682,2700094F01Rik,NET31 |
Target Alternative Names | TMEM209,Transmembrane protein 209,NET31 |
Uniprot Accession |
Q68FR5,Q8BRG8,Q96SK2
Additional SwissProt Accessions: Q68FR5,Q8BRG8,Q96SK2 |
Uniprot Entry Name | |
Protein Sub-location | Introcelluar Protein |
Category | |
Disease | |
Disease from KEGG | |
Gene Ensembl | ENSECAG00000012438, ENSCAFG00845018990, ENSBTAG00000015588, ENSMMUG00000030170, ENSMUSG00000029782, ENSG00000146842 |
Target Classification |
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.